首页> 外国专利> PEPTIDE DERIVATIVE, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, THEIR USE, METHOD OF STIMULATING RELEASE OF GROWTH HORMONE AND METHOD OF INCREASING RATE AND RANGE OF ANIMAL GROWTH, INCREASE IN MILK OR WOOL PRODUCTION OR TREATING DISEASES

PEPTIDE DERIVATIVE, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, THEIR USE, METHOD OF STIMULATING RELEASE OF GROWTH HORMONE AND METHOD OF INCREASING RATE AND RANGE OF ANIMAL GROWTH, INCREASE IN MILK OR WOOL PRODUCTION OR TREATING DISEASES

机译:包含肽的衍生物,其组成的药物组合物,其用途,刺激生长激素释放的方法以及提高动物生长速率和范围的方法,增加牛奶或羊毛的产量或治疗疾病

摘要

In the present invention there is described a peptide derivative of the general formula I, in which p represents the number 0 or 1, A represents a hydrogen atom or the group Re1-(CHi2)iq-(X)ir-(CHi2)is-CO-, B represents the group (G)it-(H)iu, in which G and H represent amino acid radicals being selected from a group comprising natural L-amino acids and their corresponding D-isomers or unnatural amino acids, C represents the radical of D-amino acid -NH-CH((CHi2)iw-Re4)-CO-, D represents the radical of D-amino acid -NRe20-((CHi2)ik-Re5)-CO- provided p is the number 1 or if p is the number 0 then D represents the group of the general formula -NRe20-CH((CHi2)il-Re5)-CHi2-Re6 or the group of the formula -NRe20-((CHi2)im-Re5)-CRe6-, E represents the group -NH-CH(Re10)-(CHi2)iv-Re9 provided that p is the number 1. All amide bonds in the general formula I, except for the bond between C and D can be substituted independently on each other with the group -Y-NRe18-, in which Y represents the group -CO- or -CHi2- and Re18 represents a hydrogen atom, alkyl containing 1 to 6 carbon atoms or aryl (having 3 to 10 carbon atoms in the ring and up to 2 hetero atoms being selected from a group comprising nitrogen atom and sulfur atom) alkyl (containing 1 to 6 carbon atoms). In the present invention there is also described a pharmaceutical preparation, in which the above-described peptide derivative is comprised.
机译:在本发明中,描述了通式I的肽衍生物,其中p代表数字0或1,A代表氢原子或基团Re 1-(CH 12)iq-(X)ir-(CH 12)是-CO-,B代表基团(G)it-(H)iu,其中G和H代表选自天然L-氨基酸及其相应的D-异构体或非天然氨基酸的氨基酸基团,C代表D-氨基酸的基团-NH-CH((CH22)iw-Re4)-CO-,D代表D-氨基酸的基团-NRe20-((CH22)ik-Re5)-CO-,p为如果数字为1或p为数字0,则D表示通式-NRe20-CH((CHi2)il-Re5)-CHi2-Re6的基团或通式-NRe20-((CHi2)im- Re5)-CRe6-,E代表基团-NH-CH(Re10)-(CH12)iv-Re9,条件是p为数字1。通式I中的所有酰胺键,除了C和D之间的键彼此独立地被基团-Y-NRe18-取代,其中Y代表基团p -CO-或-CH12-和Re18代表氢原子,含1至6个碳原子的烷基或芳基(环中具有3至10个碳原子和最多2个杂原子选自包括氮原子和硫的基团)原子)烷基(含1-6个碳原子)。在本发明中,还描述了药物制剂,其中包含上述肽衍生物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号